Madrigal Pharmaceuticals Ownership | Who Owns Madrigal Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Madrigal Pharmaceuticals Ownership Summary

Madrigal Pharmaceuticals is owned by 91.80% institutional investors, 8.76% insiders. Janus henderson group is the largest institutional shareholder, holding 10.16% of MDGL shares. Janus Concentrated Growth CF is the top mutual fund, with 2.90% of its assets in Madrigal Pharmaceuticals shares.

MDGL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Madrigal Pharmaceuticals	91.80%	8.76%	-0.56%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Janus henderson group	2.21M	10.16%	$681.37M
Rtw investments, lp	1.92M	9.58%	$536.75M
Paulson	2.04M	9.39%	$630.10M
Avoro capital advisors	2.03M	9.33%	$626.09M
Baker bros. advisors lp	1.97M	9.08%	$609.30M
Vanguard group	1.71M	7.85%	$526.46M
Blackrock	1.43M	7.14%	$399.86M
Blackrock funding, inc. /de	1.49M	6.87%	$461.06M
Fmr	867.85K	3.99%	$267.79M
State street	744.71K	3.72%	$208.64M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Paulson	2.04M	38.14%	$630.10M
Tao capital management lp	130.53K	28.11%	$40.28M
Propel bio management	43.03K	13.19%	$13.28M
University of wisconsin foundation	41.54K	9.32%	$12.82M
Avoro capital advisors	2.03M	8.86%	$626.09M
Rtw investments, lp	1.92M	8.31%	$536.75M
Baker bros. advisors lp	1.97M	6.51%	$609.30M
Affinity asset advisors	82.50K	3.41%	$25.46M
Rock springs capital management lp	265.21K	3.12%	$81.84M
Tri locum partners lp	47.47K	3.03%	$14.65M

Top Buyers

Holder	Shares	% Assets	Change
Rtw investments, lp	1.92M	8.31%	1.52M
William blair investment management	371.77K	0.28%	371.77K
Blackrock	1.43M	0.01%	216.86K
Woodline partners lp	309.12K	0.64%	162.03K
Ubs group	325.27K	0.02%	144.64K

Top Sellers

Holder	Shares	% Assets	Change
Janus henderson group	2.21M	0.35%	-269.77K
Perceptive advisors	-	-	-264.60K
Ra capital management	-	-	-204.50K
Bain capital life sciences investors	-	-	-197.00K
Braidwell lp	-	-	-183.82K

New Positions

Holder	Shares	% Assets	Change	Value
William blair investment management	371.77K	0.28%	371.77K	$114.72M
Hood river capital management	127.84K	0.58%	127.84K	$39.45M
Siren	125.94K	1.72%	125.94K	$38.86M
Norges bank	115.09K	0.00%	115.09K	$35.51M
Raymond james financial	53.85K	0.01%	53.85K	$16.62M

Sold Out

Holder	Change
Atlas capital advisors	-1.00
Cva family office	-2.00
Innealta capital	-2.00
Riggs asset managment	-2.00
Riverview trust	-2.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	300	5.63%	19,963,834	-11.66%	91	0.85%	157	20.77%	75	-14.77%
Sep 30, 2024	281	-1.75%	22,596,992	-0.11%	103	0.81%	128	-20.99%	87	31.82%
Jun 30, 2024	286	-7.44%	22,622,141	8.92%	113	1.05%	162	-1.22%	66	-20.48%
Mar 31, 2024	309	20.70%	20,769,053	6.81%	103	0.96%	164	9.33%	83	38.33%
Dec 31, 2023	256	11.30%	19,444,323	14.35%	104	1.23%	150	21.95%	60	3.45%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Janus Concentrated Growth CF	632.30K	2.90%	66.37K
Janus Henderson Forty S	632.30K	2.86%	-
Vanguard US Total Market Shares ETF	578.31K	2.62%	388.00
Vanguard Total Stock Mkt Idx Inv	517.04K	2.34%	297.00
iShares Russell 2000 ETF	472.62K	2.14%	-4.07K
Vanguard Small Cap Index	417.65K	1.89%	336.00
SPDR® S&P Biotech ETF	366.35K	1.66%	-3.92K
Janus Henderson Contrarian D	357.90K	1.62%	38.25K
Janus Henderson Opportunistic Alpha MA	319.65K	1.47%	319.62K
Janus Henderson US Opportunistic Alpha	319.65K	1.47%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 12, 2025	CRAVES FRED B	-	Sell	$914.22K
Mar 13, 2025	CRAVES FRED B	-	Sell	$533.39K
Mar 13, 2025	CRAVES FRED B	-	Sell	$629.10K
Mar 12, 2025	CRAVES FRED B	-	Sell	$524.56K
Mar 13, 2025	CRAVES FRED B	-	Sell	$292.22K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	56
2024 Q4	-	10
2024 Q3	-	1
2024 Q2	-	104
2024 Q1	2	-

MDGL Ownership FAQ

Who Owns Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals shareholders are primarily institutional investors at 91.80%, followed by 8.76% insiders and -0.56% retail investors. The average institutional ownership in Madrigal Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Madrigal Pharmaceuticals exceeds.

Who owns the most shares of Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals’s largest shareholders are Janus henderson group (2.21M shares, 10.16%), Rtw investments, lp (1.92M shares, 9.58%), and Paulson (2.04M shares, 9.39%). Together, they hold 29.12% of Madrigal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Madrigal Pharmaceuticals?

Yes, BlackRock owns 7.14% of Madrigal Pharmaceuticals, totaling 1.43M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 399.86M$. In the last quarter, BlackRock increased its holdings by 216.86K shares, a 17.92% change.

Who is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Paulson is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 38.14% of its assets in 2.04M Madrigal Pharmaceuticals shares, valued at 630.1M$.

Who is the top mutual fund holder of Madrigal Pharmaceuticals shares?

Janus Concentrated Growth CF is the top mutual fund holder of Madrigal Pharmaceuticals shares, with 2.90% of its total shares outstanding invested in 632.3K Madrigal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools